04:29 AM EDT, 05/07/2024 (MT Newswires) -- Hims & Hers Health ( HIMS ) reported Q1 earnings late Monday of $0.05 per diluted share, swinging from a loss of $0.05 a year earlier.

Analysts polled by Capital IQ expected earnings of $0.01 per share.

Revenue for the quarter ended March 31 was $278.2 million, compared with $190.8 million a year earlier.

Analysts surveyed by Capital IQ expected $268.7 million.

The company raised its full-year 2024 revenue guidance to now be between $1.2 billion and $1.23 billion, compared with the prior guidance of between $1.17 billion and $1.2 billion. Analysts surveyed by Capital IQ expect $1.2 billion.

For Q2, revenue is now projected to be $292 million to $297 million. Analysts surveyed by Capital IQ expect $290.6 million.

Shares of the company rose almost 13% in after-market hours on Monday.

Price: 13.15, Change: +1.50, Percent Change: +12.88